Professionals 642 results
Capabilities 92 results
Industry
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Practice Area
Experience 96 results
Experience
|January 22, 2026
Advised SQM on US$600M offering of subordinated capital notes due 2056 (Hybrid Bond Offering)
Experience
|January 8, 2026
Winston Represented Good Culture in its Majority Investment from L Catterton
Experience
|January 6, 2026
Brightwood Capital’s Acquisition of Museum of Illusions Group
Insights & News 5,296 results
Client Alert
|March 9, 2026
|3 Min Read
On January 27, 2026, the U.S. Department of Health and Human Services Office of Inspector General (the OIG) issued a Special Advisory Bulletin (the Bulletin) addressing the application of the federal anti-kickback statute (the AKS) to direct-to-consumer (DTC) prescription drug sales.
The Bulletin, the OIG’s first Special Advisory Bulletin since September 2014, was issued in response to the proliferation of DTC programs. The Bulletin, which sets forth the framework under which a manufacturer’s DTC program presents a low risk of violating the AKS, is viewed by the growing DTC industry as favorable guidance. DTC programs offering modern weight-loss medications, such as GLP-1 drugs, are becoming increasingly popular, and the Bulletin provides a helpful framework to support the viability of these programs.
Non-Fungible Insights: Blockchain Decrypted
|March 6, 2026
|7 Min Read
The close of 2025 highlighted the continuing momentum for the digital asset industry, with regulatory developments accelerating rather than slowing.
In the Media
|March 6, 2026
|1 Min Read
Amelia Garza-Mattia Discusses VPPA Consumer Definition Case with Law360
Other Results 130 results
Site Content
Site Content


